Last reviewed · How we verify
Fluzone I®ntradermal vaccine, 2014-2015 formulation — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Fluzone I®ntradermal vaccine, 2014-2015 formulation (Fluzone I®ntradermal vaccine, 2014-2015 formulation) — Sanofi Pasteur, a Sanofi Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Fluzone I®ntradermal vaccine, 2014-2015 formulation TARGET | Fluzone I®ntradermal vaccine, 2014-2015 formulation | Sanofi Pasteur, a Sanofi Company | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Fluzone I®ntradermal vaccine, 2014-2015 formulation CI watch — RSS
- Fluzone I®ntradermal vaccine, 2014-2015 formulation CI watch — Atom
- Fluzone I®ntradermal vaccine, 2014-2015 formulation CI watch — JSON
- Fluzone I®ntradermal vaccine, 2014-2015 formulation alone — RSS
Cite this brief
Drug Landscape (2026). Fluzone I®ntradermal vaccine, 2014-2015 formulation — Competitive Intelligence Brief. https://druglandscape.com/ci/fluzone-intradermal-vaccine-2014-2015-formulation. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab